Albinism: Clinical Trials

1 trial for Albinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Stem Cell Transplant, Myeloablative conditioning regimen - Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders
Phase 2 / Phase 3TerminatedMasonic Cancer Center, University of Minnesota222000-09-012018-01-23

Narrower conditions

Chediak-Higashi Syndrome (1)  ·  Hematologic Diseases (1)  ·  Histiocytosis, Langerhans-Cell (1)  ·  Immune System Diseases (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)  ·  Lymphoproliferative Disorders (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Histiocytosis (1)  ·  Histiocytosis, Non-Langerhans-Cell (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Leukocyte Disorders (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Lymphatic Diseases (1)  ·  Phagocyte Bactericidal Dysfunction (1)

Interventions

Busulfan (1)  ·  Cyclophosphamide (1)  ·  Stem Cell Transplantation (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)

Countries

United States (1)

Top investigators

Angela Smith, MD (1)